Sebela Pharmaceuticals Revenue and Competitors

Atlanta, GA Georgia

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Sebela Pharmaceuticals's estimated annual revenue is currently $51.9M per year.(i)
  • Sebela Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Sebela Pharmaceuticals has 258 Employees.(i)
  • Sebela Pharmaceuticals grew their employee count by -5% last year.

Sebela Pharmaceuticals's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Chief Operating Officer and General CounselReveal Email/Phone
4
CEO and PresidentReveal Email/Phone
5
VP, Quality OperationsReveal Email/Phone
6
VP, Regulatory Affairs & QA► FDA, Regulatory Strategy ★ Innovative Product DevelopmentReveal Email/Phone
7
Head R&D - GastroenterologyReveal Email/Phone
8
VP, Regulatory Affairs ► FDA, Regulatory Strategy ★ Innovative Product DevelopmentReveal Email/Phone
9
Head Corporate DevelopmentReveal Email/Phone
10
VP Market AccessReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2M20N/AN/AN/A
Add Company

What Is Sebela Pharmaceuticals?

Sebela Pharmaceuticals Inc. is committed to improving patients lives by developing, marketing and selling differentiated branded prescription pharmaceuticals that bring meaningful value to patients affected by gastrointestinal, dermatological and women's health diseases. To fulfill our commitment to improving patient's lives, we are continuing to grow our US commercial infrastructure, marketed product portfolio and late stage development pipeline in our core therapeutic areas. Our growth strategy includes in-licensing and acquiring late-stage drug candidates and marketed products that utilize and enhance our existing development and commercial capabilities. Sebela operates from two locations with an office in Roswell, Georgia, and headquarters in Dublin, Ireland.

keywords:Biotechnology,Healthcare,Pharmaceuticals

N/A

Total Funding

258

Number of Employees

$51.9M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sebela Pharmaceuticals News

2022-04-19 - Paroxetine Market Size, Share, Growth 2022-2030| Key ...

Apotex; Sebela Pharmaceuticals; Teva; Mylan; Sun Pharmaceutical; Lupin; Lannett Company; Aurobindo; Jubilant Pharma; Sciecure Pharma. Paroxetine...

2022-04-17 - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs ...

The producers involved in the industry cover: Bausch Health; Allergan; Sebela Pharmaceuticals; Astellas Pharmaceuticals; Amneal Pharms; Pharscin Pharma. ACCESS...

2022-04-06 - HK inno.N says it confirmed K-Cab's safety in US trial

... subsidiary of Sebela Pharmaceuticals which focuses on gastroenterology. ... In China, Shandong Luoxin Pharmaceutical Group seeks to win...

2021-03-23 - CellMax Life and Sebela Pharmaceuticals Enter Strategic Development and Commercialization Partnership for FirstSight™ Blood Test for Detection of Colorectal Cancer and Pre-Cancer

SUNNYVALE, Calif. and ROSWELL, Ga., March 23, 2021 /PRNewswire/ -- CellMax Life, a molecular diagnostics company with proprietary technology for pre-cancer and cancer detection blood tests, and Sebela Pharmaceuticals, a market leader in gastroenterology, announce the closing of a strategic devel ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$73.3M2727%N/A
#2
$92.2M2897%N/A
#3
$127.9M31010%N/A
#4
$58.2M3211%N/A
#5
$121.4M3875%N/A